|Bid||13.60 x N/A|
|Ask||14.90 x N/A|
|Day's Range||13.50 - 13.80|
|52 Week Range||11.50 - 33.60|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for PHIA.DU
The Radiology Operations Command Centre interface Clinicians collaborate over a virtual chat Preparation of a patient for an MR 5300 scan Spectral CT product side view A child prepares for an MR scan relaxing using the Philips Pediatric Coaching app November 27, 2022 Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency to address workforce shortages and staff burnout and enable a clear care pathway for every patient Amsterdam,
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The U.S. Food and Drug Administration (FDA) on Wednesday said Philips filed 21,000 medical device reports in connection with faulty foam in its ventilation and sleep apnoea devices in the Aug-Oct 2022 period. Philips has been recalling 5.5 million such devices since June 2021 after it became aware that a foam part can deteriorate and threaten users' health. In a statement, Philips said that it believes the large number of reports are a result of publicity around the issue, which has wiped 30 billion euros off its market valuation.